Apolipoprotein A1 is associated with pulmonary vascular resistance and adverse clinical outcomes in patients with pulmonary hypertension secondary to heart failure

Apolipoprotein A1 is associated with pulmonary vascular resistance and adverse clinical outcomes in patients with pulmonary hypertension secondary to heart failure

Abstract Pulmonary hypertension secondary to heart failure (HF‐PH) combined with pulmonary vascular remodeling has a high mortality rate. Apolipoprotein A1 (ApoA1) has been shown to adversely affect outcomes in patients with HF. A prospective follow‐up study was performed on 239 consecutive patients...

Full description

Bibliographic Details
Main Authors: Wande Yu, Xie Dujiang, Wang Yi, Ding Guanwen, Zhang Mengyu, Pan Chang, Zhang Aikai, Zhang Juan, Zhu Linlin, Zhang Hang
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Pulmonary Circulation
Subjects:
ApoA1
pulmonary hypertension
pulmonary hypertension secondary to heart failure
pulmonary vascular remodeling
Online Access:https://doi.org/10.1002/pul2.12096

Internet

https://doi.org/10.1002/pul2.12096

Similar Items